Biohaven Ltd
General ticker "BHVN" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $4.0B
Biohaven Ltd follows the US Stock Market performance with the rate: 16.6%.
Estimated limits based on current volatility of 3.9%: low 34.38$, high 37.16$
Factors to consider:
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [17.25$, 43.89$]
- 2024-12-30 to 2025-12-30 estimated range: [9.24$, 26.60$]
Short-term BHVN quotes
Long-term BHVN plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $462.51MM | $0.00MM | $0.00MM |
| Operating Expenses | $1,166.55MM | $567.93MM | $436.05MM |
| Operating Income | $-704.04MM | $-567.93MM | $-436.05MM |
| Non-Operating Income | $-139.28MM | $-1.91MM | $26.50MM |
| R&D Expense | $181.49MM | $437.07MM | $373.28MM |
| Income(Loss) | $-843.32MM | $-569.84MM | $-409.55MM |
| Taxes | $5.07MM | $0.44MM | $-1.38MM |
| Profit(Loss) | $-848.40MM | $-570.28MM | $-408.17MM |
| Stockholders Equity | $-739.38MM | $538.77MM | $427.98MM |
| Inventory | $6.73MM | $56.16MM | $0.40MM |
| Assets | $1,077.21MM | $661.78MM | $513.21MM |
| Operating Cash Flow | $-831.10MM | $-297.69MM | $-331.73MM |
| Capital expenditure | $0.94MM | $41.07MM | $3.05MM |
| Investing Cash Flow | $26.55MM | $-304.79MM | $129.83MM |
| Financing Cash Flow | $844.85MM | $767.60MM | $211.91MM |
| Earnings Per Share* | $-5.97 | $-12.75 | $-5.73 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.